Abstract Library

#2117 Neuroendocrine Tumors: An Australian Experience

Introduction: Neuroendocrine tumours (NETs) in Australia are rare, but are rising in incidence.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Ashoka Menon V, Reeders J, George M,

Keywords: retrospective, incidence, low to intermediate, neuroendocrine, australia,

#2091 Differential Signalling Pathways Drive Therapeutic Resistance in Neuroendocrine Tumors

Introduction: Most of the current therapeutic strategies used for neuroendocrine tumors (NETs) are insufficient due to poor knowledge of these tumours. Despite showing differentiated features, NETs often exhibit therapeutic resistance to common treatments similarly to other cancers. Although signalling abnormalities have been reported, molecular mechanisms responsible for this resistance phenomenon are yet to be understood.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Romano D, Gerard C, Poizat F, Niccoli P, Barlier A,

Keywords: neuroendocrine tumors, drug resistance, proteomics, kinases, apoptosis,

#1553 A Novel In Vitro Model of a Highly Proliferative Pancreatic Neuroendocrine Neoplasia

Introduction: Transformation of well-differentiated neuroendocrine tumors into highly proliferative neuroendocrine neoplasms is a rare, but clinical relevant phenomenon. So far, it is unclear whether these tumors should be treated in analogy to neuroendocrine tumors or as bona fide neuroendocrine carcinoma.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Schrader J

Authors: Behrang Y, Benten D, Erbes J, Eggers C, Fahl M,

Keywords: cell line,

#1243 Neuroendocrine Carcinomas of the Prostate

Introduction: Since focal neuroendocrine (NE) differentiation in prostate carcinomas represents a frequent phenomenon when NE markers are used for documentation, NE carcinomas are extremely rare form of highly aggressive prostate tumors.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Dema A, Taban S, Anderco D, Bardan R, Daminescu L,

Keywords: neuroendocrine, carcinoma, prostate,

#1239 Histological Classification of Pancreatic Neuroendocrine Tumours: Optimising the Ki67 System

Introduction: Pancreatic neuroendocrine tumours are graded using the Ki67 antigen in accordance with the WHO 2010 classification. Despite the system’s widespread use, a wide variety of tumour behaviours have been described leading to various proposed revisions.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Mills L, Ramage J, Prachalias A, Srinivasan P, Menon K,

Keywords: G3,